While a JNK-independent role of Egr in PS exposure and sensitivity to the AMP cannot be ruled out, TNF might also sensitise cells through activation of the JNK pathway (Cordero et al., 2010) and PS exposure, thus providing a secondary sensitisation mechanism of tumour cells to the action of Defensin. The gene discussed is MAPK8; the disease is neoplasm.